JF
Jump Financial Portfolio holdings
AUM
$8.14B
1-Year Return
18.67%
This Quarter Return
+0.68%
1 Year Return
+18.67%
3 Year Return
+54.31%
5 Year Return
+107.56%
10 Year Return
–
AUM
$4.97B
AUM Growth
+$1.3B
(+35%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
24.34%
Top 10 Holdings %
Top 10 Hldgs %
20.66%
Holding
2,385
New
513
Increased
636
Reduced
565
Closed
646
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$201M |
| 2 |
NVIDIA
NVDA
|
+$57.4M |
| 3 |
Broadcom
AVGO
|
+$44M |
| 4 |
Apple
AAPL
|
+$36.8M |
| 5 |
Amazon
AMZN
|
+$31M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$121M |
| 2 |
ProShares UltraPro Short QQQ
SQQQ
|
+$32.1M |
| 3 |
UnitedHealth
UNH
|
+$16.7M |
| 4 |
Biogen
BIIB
|
+$13M |
| 5 |
Zoetis
ZTS
|
+$12.8M |
Sector Composition
| 1 | Technology | 20.92% |
| 2 | Consumer Discretionary | 10.34% |
| 3 | Healthcare | 10.28% |
| 4 | Industrials | 9.9% |
| 5 | Financials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Amkor Technology
AMKR
$6.29B
| $885K | 0.02% |
22,104
-32,696
| -60% | -$1.31M |
|
852
Prothena Corp
PRTA
$442M
| $883K | 0.02% |
42,800
+14,849
| +53% | +$306K |
|
853
Unifirst Corp
UNF
$3.18B
| $882K | 0.02% |
5,141
+3,510
| +215% | +$602K |
|
854
Fresh Del Monte Produce
FDP
$1.71B
| $880K | 0.02% |
40,285
+18,260
| +83% | +$399K |
|
855
Acco Brands
ACCO
$361M
| $877K | 0.02% |
186,697
+61,205
| +49% | +$288K |
|
856
ProFrac Holding
ACDC
$671M
| $877K | 0.02% |
118,384
+92,284
| +354% | +$684K |
|
857
Plains All American Pipeline
PAA
$12.3B
| $875K | 0.02% |
49,000
-138,400
| -74% | -$2.47M |
|
858
Omnicom Group
OMC
$15B
| $873K | 0.02% |
9,733
+3,786
| +64% | +$340K |
|
859
Sprout Social
SPT
$803M
| $871K | 0.02% |
+24,400
| New | +$871K |
|
860
Driven Brands
DRVN
$3B
| $869K | 0.02% |
68,300
+54,157
| +383% | +$689K |
|
861
Goldman Sachs
GS
$236B
| $866K | 0.02% |
1,914
-2,661
| -58% | -$1.2M |
|
862
OneSpaWorld
OSW
$2.24B
| $865K | 0.02% |
56,300
+13,495
| +32% | +$207K |
|
863
ADMA Biologics
ADMA
$3.84B
| $862K | 0.02% |
77,105
-259,767
| -77% | -$2.9M |
|
|
CDMO
864
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $858K | 0.02% |
120,200
-59,775
| -33% | -$427K |
|
865
Gray Television
GTN
$598M
| $858K | 0.02% |
165,000
+57,868
| +54% | +$301K |
|
866
Regenxbio
RGNX
$465M
| $854K | 0.02% |
+72,975
| New | +$854K |
|
867
Charles River Laboratories
CRL
$7.52B
| $851K | 0.02% |
4,118
+3,052
| +286% | +$630K |
|
|
FLG
868
Flagstar Financial, Inc.
FLG
$5.27B
| $849K | 0.02% |
+87,898
| New | +$849K |
|
869
Veeva Systems
VEEV
$45.3B
| $848K | 0.02% |
+4,631
| New | +$848K |
|
870
Heidrick & Struggles
HSII
$1.03B
| $847K | 0.02% |
+26,817
| New | +$847K |
|
|
ELME
871
Elme Communities
ELME
$1.51B
| $846K | 0.02% |
+53,106
| New | +$846K |
|
872
LifeMD
LFMD
$275M
| $846K | 0.02% |
123,294
+14,785
| +14% | +$101K |
|
873
Arvinas
ARVN
$568M
| $846K | 0.02% |
+31,762
| New | +$846K |
|
874
Ocular Therapeutix
OCUL
$2.23B
| $844K | 0.02% |
123,442
+80,123
| +185% | +$548K |
|
875
ALX Oncology
ALXO
$56.8M
| $844K | 0.02% |
140,000
+115,194
| +464% | +$695K |
|